Terveystalo Oyj
TTALF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.08 | 0.13 | -0.90 | 0.25 |
| FCF Yield | 11.63% | 7.89% | 5.34% | 10.22% |
| EV / EBITDA | 9.60 | 22.97 | 11.94 | 9.95 |
| Quality | ||||
| ROIC | 7.98% | -1.34% | 2.12% | 7.18% |
| Gross Margin | 58.97% | 23.57% | 58.25% | 57.66% |
| Cash Conversion Ratio | 2.50 | -4.06 | 4.56 | 1.94 |
| Growth | ||||
| Revenue 3-Year CAGR | 2.10% | 3.67% | 8.48% | 3.86% |
| Free Cash Flow Growth | 57.35% | 43.21% | -46.29% | 37.52% |
| Safety | ||||
| Net Debt / EBITDA | 2.32 | 6.60 | 3.23 | 2.57 |
| Interest Coverage | 4.15 | -0.65 | 3.46 | 11.71 |
| Efficiency | ||||
| Inventory Turnover | 76.36 | 138.48 | 79.65 | 76.38 |
| Cash Conversion Cycle | 0.39 | 20.46 | 5.87 | -0.43 |